Hispanic Heritage Month and Psychedelics
Celebrate National Hispanic Heritage Month by expressing gratitude for Hispanic and Latinx visionaries, researchers, community members, and others who have expanded awareness about psychedelics. Taking …
Participant Safety in Psychedelic Therapy
All stakeholders at the Multidisciplinary Association for Psychedelic Studies (MAPS) and MAPS Public Benefit Corporation (MAPS PBC) are committed to providing quality and comprehensive training and supervision …
MAPS-Sponsored Global Psychedelic Survey Gathers Data for a Crucial View into Psychedelic Use
FOR IMMEDIATE RELEASE: May 22, 2023 The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the launch of the Global Psychedelic Survey. Co-sponsored by MAPS, SABI Mind, Mind Medicine …
FDA Grants In-Person Type A Meeting Request to Discuss Clinical Hold on Phase 2 Study of Cannabis for Veterans with PTSD (MJP2)
After reviewing MAPS’ Type A Meeting Request and Briefing submitted on April 28, the FDA granted MAPS’ meeting request. MAPS and the FDA will have a face-to-face formal meeting to discuss the …
MAPS Requests FDA for a Type A Meeting to Discuss Clinical Hold for the Phase 2 Study of Cannabis for Veterans with PTSD (MJP2)
On April 28, 2023, MAPS requested the FDA for a Type A meeting to discuss the clinical hold issues for Study MJP2 in order to overcome the clinical hold deficiencies. This meeting request is in response …
Celebrating 37 Years of Psychedelic Science🎉
“You and I are the force for transformation in the world. We are the consciousness that will define the nature of the reality we are moving into.” Ram Dass Today is MAPS’ 37th anniversary! Almost …
STATEMENT: MAPS-Funded Phase 3 Research Reports Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for PTSD
FOR IMMEDIATE RELEASE: April 5, 2023 MAPS Public Benefit Corporation (MAPS PBC), a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), announced preliminary findings …
Grammy and Academy Award-Winning Music Icon Melissa Etheridge to Speak at Psychedelic Science 2023
Rock Star and Activist to speak about addiction, family, and the healing potential of plant medicine FOR IMMEDIATE RELEASE: March 17, 2023 SOURCE: Psychedelic Science Today, Psychedelic Science 2023, the …
Q4 2022 Progress Report for Phase 2 Study of Cannabis for Veterans with PTSD (MJP2) #2
On March 14, 2023, MAPS released a progress report for Phase 2 Study of Cannabis for Veterans with PTSD (MJP2). Read the Q4 2022 progress report here.
Psychedelic Science 2023 Announces Initial Agenda and Select Featured Speakers for the Largest Gathering of Psychedelic Professionals in the Country
Super Bowl Champion Quarterback Aaron Rodgers, Author & Journalist Michael Pollan, U.S. Olympian Sasha Cohen, Co-Founder of Whole Foods John Mackey, Lieutenant Diane M. Goldstein (Ret.), and Famed …
Big, if True: Did Australia Legalize MDMA and Psilocybin?
Distinctions in Australian MDMA and Psilocybin Policy The Therapeutic Goods Administration (TGA) in Australia recently announced a new policy allowing for the limited use of psychedelic-assisted therapies …
Statement: Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme
FOR IMMEDIATE RELEASE: February 3, 2023 The Therapeutic Goods Administration (TGA) in Australia announced today that they will permit limited use of certain psychedelic-assisted therapies for the treatment …